GlassScriptPhysician profile
Carl M Jean
NPI 1255453031
$16,612.81
in general payments reported to CMS, 2019-2025
25 companies · $2,273 in 2025
The $2,273 reported for 2025 was more than what 85% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,321 · 2020: $1,143 · 2021: $2,793 · 2022: $3,097 · 2023: $1,145 · 2024: $1,840 · 2025: $2,273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,129 · Travel and Lodging: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,128.75 |
| Travel and Lodging | $130.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Royal Biologics, INC. | $5,225.49 | 2019-2022 | |
| Stryker Corporation | $3,855.61 | 2020-2025 | Easyfuse, Citrefix, Prostep Mica |
| Gotham Surgical Solutions & Devices, INC. | $1,200.00 | 2022 | |
| Abbott Laboratories | $1,068.83 | 2022-2025 | Aveir, Gallant |
| Smith+Nephew, INC. | $1,034.54 | 2019-2021 | |
| Treace Medical Concepts, INC. | $723.59 | 2021-2023 | |
| Averitas Pharma INC. | $387.98 | 2024-2025 | Qutenza |
| Medimetriks Pharmaceuticals, INC. | $350.00 | 2019 | |
| Shockwave Medical, INC | $337.30 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Wright Medical Technology, INC. | $300.44 | 2019-2020 | |
| Boston Scientific Corporation | $293.18 | 2024-2025 | General - Therapies, Avvigo Guidance System |
| Medtronic, INC. | $257.38 | 2024-2025 | Closurefast |
| Kerecis Limited | $251.46 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Integra Lifesciences Corporation | $227.12 | 2022 | |
| Misonix INC | $171.38 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $150.00 | 2024 | Bun-Yo-Matic |
| Trilliant Surgical LLC. | $144.66 | 2019 | |
| Ets Wound Care LLC | $128.43 | 2023 | |
| Pfizer INC. | $120.20 | 2019 | |
| Nevro Corp. | $87.12 | 2022 | |
| Osteomed LLC | $82.34 | 2019-2020 | |
| Cardiovascular Systems INC. | $78.04 | 2020 | |
| Osiris Therapeutics INC. | $72.80 | 2019 | |
| Linvatec Corporation | $48.35 | 2025 | Biobrace 23mm |
| Acumed LLC | $16.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Jean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.